Reviewing P3 Health Partners (PIII) and Its Rivals

P3 Health Partners (NASDAQ:PIII) is one of 32 publicly-traded companies in the “Health services” industry, but how does it compare to its competitors? We will compare P3 Health Partners to related businesses based on the strength of its earnings, valuation, dividends, institutional ownership, analyst recommendations, profitability and risk.

Earnings and Valuation

This table compares P3 Health Partners and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
P3 Health Partners	$1.14 billion	-$270.13 million	0.00
P3 Health Partners Competitors	$1.69 billion	-$102.87 million	22.81

P3 Health Partners’ competitors have higher revenue and earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares P3 Health Partners and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-10.92%	-2,471.27%	33.63%
P3 Health Partners Competitors	-163.10%	-230.92%	-18.53%

Insider and Institutional Ownership

23.6% of P3 Health Partners shares are owned by institutional investors. Comparatively, 46.9% of shares of all “Health services” companies are owned by institutional investors. 17.1% of P3 Health Partners shares are owned by company insiders. Comparatively, 22.9% of shares of all “Health services” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Risk and Volatility

P3 Health Partners has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, P3 Health Partners’ competitors have a beta of 1.50, meaning that their average share price is 50% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for P3 Health Partners and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	0	1	1	0	2.50
P3 Health Partners Competitors	10	158	310	0	2.63

P3 Health Partners currently has a consensus target price of $5.00, suggesting a potential upside of 135.85%. As a group, “Health services” companies have a potential upside of 109.04%. Given P3 Health Partners’ higher probable upside, research analysts plainly believe P3 Health Partners is more favorable than its competitors.

Summary

P3 Health Partners competitors beat P3 Health Partners on 9 of the 12 factors compared.

About P3 Health Partners

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.